About
TB Vaccine
Areas of Focus
Categories
Vaccine
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
356
By Phase
PHASE2: 5PHASE2/PHASE3: 1PHASE1: 2
By Status
COMPLETED: 3WITHDRAWN: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05455112Lead Sponsor
Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis
PHASE2Recruiting
44 participants
Started: Oct 29, 2022 · Completed: Dec 31, 2024
NCT05115019Collaborator
A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)
PHASE2/PHASE3Withdrawn
Started: Dec 31, 2021 · Completed: Apr 30, 2022
NCT05136833Lead Sponsor
Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients
PHASE2Withdrawn
Started: Dec 1, 2021 · Completed: Dec 31, 2022
NCT04919239Lead Sponsor
Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)
PHASE2Active, not recruiting
140 participants
Started: Sep 22, 2021 · Completed: Mar 31, 2025
NCT02711735Lead Sponsor
Safety of RUTI® Vaccination in MDR-TB Patients
PHASE2Terminated
9 participants
Started: Mar 18, 2020 · Completed: Sep 9, 2020
Locations (1)
Headquarters
Barcelona, Spain
Map
Loading map...